The composition of tumor-infiltrating lymphocytes (TIL) often reflects the host's immune response to the tumor. To study the relationship of TIL and carcinoma-associated T/Tn antigens in breast carcinoma, a straightforward concurrent immunoenzyme staining procedure was developed. Fresh tissue was directly fied in a zinc-based fixative to preserve lymphocyte markers and then routinely embedded in paraffii. The TIL subtypes in the sections were identified in the first immunostaining cyde by reaction with a monodonal antibody (MAb) to lymphocyte markets CD3, CD4, CD8, CD19, or CD56, followed by a modified avidin-biotin procedure and diaminoknzidine tetrahydrochloride-HzO~ for color development. This was followed by paraformaldehyde fixation to block antibody crossreactivity. The T and Tn
Introduction
Understanding of the relationship between tumor-infitrating lymphocytes (TIL) and tumor-associated antigens is important. Composition of TIL subsets and their correlation with tumor cells may reflect an immune response of the patient to the tumor and may provide valuable parameters for prognostication and immunointervention. Studies of TIL expanded with interleukin-2 in vitro demonstrated that they were therapeutically 50-100-fold more effective than were lymphokine-activated killer cells (1, 2) . TIL suspensions isolated from fresh surgical human breast carcinoma specimens were analyzed and have been shown to be composed of different kinds of immune cells; a heterogeneous population of T-cells predominated and there was also an accumulation of B-cells (3). However, the factors and mechanisms responsible for eliciting different functional subsets of TIL and their location in vivo remain obscure. Immunohistochemical staining should be a power- antigens on carcinoma cells were then demonstrated in a second staining cyde by reaction with an MAb against T or Tn antigen, followed by an indirect immunoalkaline phosphatase procedure and corresponding substrate systems for color development. The distinguishable brown color for TIL and blue or red color for T or Tn antigen enabled us to identify the TIL subsets and to describe their relations with T/Tn antigen expression in situ. This approach may contribute to better understanding of the patients' immune defenses against their tumor and aid in prognostication. 19%) KEY WORDS: Concurrent immunoenzyme staining; Zinc fixative; Human pancarcinoma T/Tn antigens; Tumor-infiltrating lymphocytes; Breast carcinoma. ful tool in subclassification of TIL. Unfortunately, study of ordinary paraffin-embedded tissues is hindered because the majority of lymphocyte subpopulation markers are destroyed by formalin fixation and therefore can not be identified in situ by immunostaining of routinely formalin-fixed tissue sections (4). Antigen retrieval approaches, including microwave treatment, showed little improvement in the demonstration of lymphocyte subtype markers (5). Frozen section technique does improve antigen survival (4), but the suboptimal morphology and inconvenience limit its application. Recently, Beckstead (4) reported a gentle technique for preservation of fixation-sensitive antigens using a simple buffer containing zinc as the primary fixative, followed by routine paraffin embedding. Experiments in our laboratories reported here confirm that formalin fixation did not preserve lymphocyte subgroup antigens but that zinc fixation did. The zinc fixation procedure is also convenient and reliable for preservation of tumor-associated antigens. On the basis of this technique, we have set up a concurrent immunostaining method to study a possible correlation between the extent of carcinoma-T and -Tn epitope (EP) expression and elicitation of cell-mediated immune responses.
T EP (Gal~1~3-GalNAc-a-O-SerlThr) and its immediate precursor Tn EP (GalNAc-a-0-Ser/Thr) are immunoreactive pan-187 carcinoma EPs on T and Tn antigens (6,7), the Ca antigen (8), and the polymorphic epithelial mucin product of the MUCl gene (9,lO). Immunoreactive T and Tn EPs are present in approximately 90% of carcinomas (11) but are masked in normal human tissues (12J3). Unmasked T/Tn EPs elicit both cellular and humoral autoimmune responses (10) . In this study, T/Tn antigens on breast carcinoma cells and the subsets of TIL in the original carcinoma environment are simultaneously identified in the same paraffin section of zinc-based solution-fixed tissues using sequential concurrent immunoenzyme staining procedures.
Materials and Methods
Antibodies and Reagents. Monoclonal antibodies (MAbs) to lymphocyte-associated antigens CD3 (14), CD4 (15), CD8 (U), CD19 (16), CD56 (17). biotinylated goat anti-mouse immunoglobulins, and streptavidin-biotin complex (SABC) were purchased from Dako (Carpinteria, CA). Mouse antiT ascites MAb RS1-114 was the h n d gift of Dr. R. Stein (18) . Mouse anti-Tn ascites MAb BaGS-3 was elicited with isolated 0 red blood cell Tn antigen (7). Alkaline phosphatase conjugated goat anti-mouse immunoglobulins, 5-bromo-4-chloro-3-indolyl phosphatelnitro blue tetrazolium (BCIPINBT), new fuchsinlnaphthol phosphate substrate systems, and levamisole were purchased from BioGenex (San Ramon, CA). Bovine serum albumin (BSA), calcium acetate, diaminobenzidine tetrahydrochloride (DAB), dimethylsulfoxide (DMSO), PBS, p H 7.4, Tris base, Zn acetate, and zinc chloride (ZnC1) were purchased from Sigma (St Louis, MO).
Tissue Preparation. The use of human breast carcinoma tissue was approved by the Institutional Review Boards of the Chicago Medical School and Evanston Hospital.
Fresh surgical specimens from seven different breast carcinomas, among them four with corresponding axillary lymph nodes, were sliced into 2-3mm-thick pieces and processed by the method of Beckstead (4). Fixation was in 0.5% ZnCI, 0.5% Zn acetate in 0.1 M Tris base buffer containing 0.05% calcium acetate, pH 7.0-7.4, for 48 hr at room temperature (RT). After fixation the tissues were consecutively dehydrated for 2 hr each in 50%. 70%. 95%, and 100% ethanol, then cleared in xylene for 1 hr, two changes, 30 min each, at RT and infiltrated with paraplast X-tra (Oxford Labware; St Louis, MO) at 58-6O' C with three changes, 10 min each, and then embedded in paraplast X-ua. In general, the breast carcinoma and corresponding axillary lymph node tissues were embedded in the same blocks to serve as internal positive controls for lymphocyte markers. Parallel tissue specimens, routinely fixed in formalin and embedded in paraffin, were used for comparison. Concurrent Immunohistochemical Staining. Routine 5-wm sections were cut and floated on water at 43"C, collected on coated slides (SuperFrostlPlus; Fisher Scientific, Pittsburgh, PA), and dried at RT overnight. The sections were deparaffinized in three changes of xylene, 3 min each, followed by three changes of 100% ethanol, 1 min each. They were rehydrated through 95% and 70% ethanol to tapwater, then washed in Tris-buffered saline (TBS), pH 7.2-7.6, with 5 % DMSO for 10 min and rinsed in TBS. Thereafter, the staining was done in Sequenza immunostaining racks with coverplates (Shandon, Pittsburgh, PA) at RT. The immunoperoxidase technique using a modified avidin-biotin procedure (19) was performed first to identify TIL markers. Slides were incubated with 0.3% BSA in TBS with 0.1% sodium azide (BSA-TBS) for 10 min to block nonspecific protein binding sites, followed by incubation with an MAb to the lymphocyte marker diluted in BSA-I'BS according to the manufacturer's instructions (antibody against CD3, 1:lOO; CD4, 120; CD8, 1:lOo; CD19, 1230; CD56, 1:40)for 1 hr, then rinsed with TBS containing 0.05 % Tween 20 (TBS-Tween 20) three times for 5 min each, incubated in biotinylated goat anti-mouse immunoglobu-lins (1:600) for 30 min, rinsed three times in TBS-Tween 20, followed by fresh 3% Hz02 in 80% methanol with 0.1 M sodium azide incubation for 30 min to quench endogenous peroxidase activity, rinsed three times in TBS-Tween 20, then incubated with SABC (1:800) for 30 min. rinsed twice in TBS-Tween 20 and once in TBS, followed by color development with 0.05% DAB + 0.01% H202 in PBS for 7 min and rinsed three times in TBS. Then the sections were fixed in 4% paraformaldehyde in PBS for 15, 30, or 60 min to stabilize the reaction complex. Thereafter, the indirect immunoalkaline phosphatase procedure (20) was used in the second staining cycle to demonstrate T or Tn antigens: the slides were incubated with an MAb against T antigen (RS1-114, 1:lOO) or Tn antigen (BaGS-3, 1~40) for 1 hr, rinsed three times in TBS-Tween 20, followed by incubation with alkaline phosphatase-conjugated goat anti-mouse immunoglobulins (ready to use) for 30 min, rinsed twice in TBS-Tween 20, and rinsed once in TBS. pH 9.0. Color development was by incubation with BCIP/NBT for T-antigen or new fuchsinlnaphrhol phosphate substrate system for Tn antigen for 13-20 min. Levamisol was added to the substrate just before use at a final concentration of 0.6 mglml to inhibit endogenous alkaline phosphatase activity for both T and Tn staining. After a rinse in distilled water, some sections were counterstained with Harris' modified hematoxylin (Fisher Scientific; Pittsburgh, PA) for 1 min and rinsed in distilled water. Then all slides were taken out of the immunostaining racks and rinsed in tapwater, dehydrated in 70% and 95% ethanol for 5 min each, followed by three changes of 100% ethanol of 3 min each, then cleared in xylene, three changes of 3 min each, and mounted with Cytoseal 60 (Stephens Scientific; Riverdale, NJ). Negative controls included omission of primary antibodies and substitution of primary antibodies with control mouse ascites fluid in the first and second staining cycle, respectively.
Results
The morphology of the ZnCI/Zn acetate-fixed tissues was well preserved. The antigens of all TIL subsets tested were clearly demonstrated by a strong brown color. The color was stable and remained well-distinguishable after the additional secondary cycle staining procedures. Figures 1 through 4 show typical cases. The staining intensity and clarity of TIL in breast carcinoma tissue ( Figures 1A  and 2A ) are similar to those of corresponding lymphocyte subsets in the lymph nodes embedded in parallel in the same paraffin block ( Figures 1B and 2B ). T antigens on breast carcinoma cells were stained blue with the BCIPINBT substrate system ( Figure 1A ), whereas the Tn antigens were stained red by using the new fuchsin substrate system (Figures 2A, 3, and 4 ). Both carcinoma cell membranes and cytoplasm stained positively for T and Tn antigens.
In the specimens studied the main subpopulations of TIL were CD3' T-lymphocytes ( Figure 1A) . The ratio of CD4' T-helperlinducer cells to CD8' T-cytotoxic cells varied and was either greater or less than 1 with the individuals from whom the specimens were obtained. Both CD4' and CD8' T-cells had a close spatial relationship to the carcinoma cells, especially the CD8' cells, which often infiltrated into the carcinoma tissues (Figures 2A and 3) . In contrast, the CD19' B-lymphocytes were mainly present as aggregates, surrounded by other types of TIL (Figure 4) . Only a few CD56' cells scattered throughout the lymph node were observed; none were seen among TIL (not shown).
In our experiments, the results were closely similar when the paraformaldehyde fixative was applied for 15, 30 or 60 min after the first staining cycle, but the TIL stainings were sometimes not sharp enough when this treatment was omitted (data not shown).
In routine formalin-fixed tissues there was no staining of the y& c lymphocyte markers studied. The T and Tn antigens on carcinoma cells were positively stained, similar to those seen in zinc solutionfixed tissues. However, the latter yielded generally stronger staining intensity on carcinoma cell membranes. None of the negative controls showed any staining for TIL markers or for T and Tn antigens.
Discussion
In this study, a concurrent immunostaining technique was employed to demonstrate separate antigens on distinct cells in the same tissue section. This procedure gave clear cut results. Among various multiple immunolabeling methods, the indirect immunostaining approach using primary antibodies from the same animal species throughout, such as mouse MAbs, is the most attractive because of its widespread applicability (21). The main problem with this technique is the possible crossreaction caused by the free combining sites of the secondary antibody (such as goat anti-mouse immunoglobulins) in the first staining cycle binding to the primary antibodies applied in the second staining cycle. There are several methods to block this crossreaction. One utilizes paraformaldehyde vapors to destroy the antigen binding sites on the secondary antibodies ( 2 2 ) . Another approach, recently reported, is the use of microwave oven heating to block the antibody crossreactivity ( 2 3 ) . A third way is to utilize the enzyme-substrate reaction products to mask the reagent complex of the first staining sequence ( 2 4 ) .
In this study we employed the third modification. Our results show no color mixing between the two staining sequences. The product of DAB is effective enough to shelter the reagent complex in the first staining sequence from reaction with reagents used in the second staining cycle ( 2 4 ) . In addition, after the first staining cycle, the paraformaldehyde fixative treatment was applied to further stabilize the reaction complex and reduce the possibility of crossreaction. The entire concurrent immunostaining procedure was performed in the Sequenza immunostaining rack without changing staining jars; hence, it is more convenient and timesaving than related methods. One aim of this study was to classify the subtypes of TIL in tumor tissue. In agreement with Beckstead's results ( 4 ) , in our experiments the lymphocyte antigens that we used to distinguish the subsets were fixation-sensitive and could not be demonstrated in routine formalin-fixed and paraffin-embedded tissues. Using ZnCI/Zn acetate fixative, instead of formalin, enabled us to preserve these lymphocyte antigens, not only in lymph node tissues but also on lymphocytes within tumor tissues. Furthermore, the zinc fixative also improved the antigen survival of the formalinresistant T and Tn antigens, resulting in stronger staining intensity on tumor cell membranes.
The successful fixation of lymphocyte antigens enabled us to identify sub-types of TIL, and we will study in the future the possible interactions between TIL and breast carcinoma cells. To obtain reliable and reproducible results, it is recommended that formalinsensitive antigens be stained in the first staining cycle and that the fixation-resistant antigens be stained in the second cycle. Further studies on a large series of primary breast carcinomas may permit correlation of TIL density, proportion of various TIL subsets and their interaction with carcinoma cells with the biological aggres-siveness of the carcinoma and with the defense capabilities of the patient, and aid in the prognostication of the disease. Because TIL antigens and carcinoma-associated antigens other than T and Tn can be simultaneously demonstrated by this approach, it may find broad applications in tumor immunology. 
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